Radiopharmaceutical Therapies Market to reach US$31.65bn
22 October 2026.The global Radiopharmaceutical Therapies market is projected to grow at a CAGR of 15.3% by 2036
Battlefield lessons, modular systmens and the power bottleneck; News and coverage from the event.
The race to electrify and next gen mobility; our coverage on the latest developments shaping automotive strategy.
The global Radiopharmaceutical Therapies market is projected to grow at a CAGR of 15.3% by 2036
The global Small Modular Reactor (SMR) market is projected to grow from US$6.10 billion in 2027 to US$22.85 billion by 2037, representing a 14.1% CAGR during the forecast period.
Biopharma manufacturers compete for contracts, specialist capabilities and sustainable growth
Britain’s Hybrid Navy faces challenges turning autonomous surveillance into capability
The global market is expected to expand from US$32.28bn in 2026 to US$117.20bn by 2036, at a 13.8% CAGR
mRNA advances raise manufacturing demands, but CDMO returns remain uncertain
The global Microreactor market is projected to grow from US$482.8 million in 2027 to US$1,531.8 million by 2037, at a CAGR of 12.2%.
The Peptide Contract Manufacturing market is projected to grow at a CAGR of 12.7% by 2036
The global nuclear fuel market is projected to grow from US$36.08 billion in 2027 to US$72.24 billion by 2037.
The Biopharmaceuticals Contract Manufacturing market is projected to grow at a CAGR of 12.7% by 2036
Biologics outsourcing and demand for specialist manufacturing capacity are driving 9.7% CAGR through 2036.
The global market is expected to expand from US$142.55bn in 2026 to US$459.75bn by 2036, at a 12.4% CAGR
DroneX 2026 highlights mounting pressures on drone manufacturing and procurement
CPHI Milan examines what turns pharmaceutical innovation into commercial scale
The global market is expected to expand from US$43.70bn in 2026 to US$166.36bn by 2036, at a 14.3% CAGR
CPHI Milan tests manufacturing capability, execution, validation and proven performance
The global market is expected to expand from US$75.67bn in 2026 to US$257.09bn by 2036, at a 13.0% CAGR
CPHI Milan highlights specialist capacity, resilient supply and scalable AI
The global market is expected to expand from US$9.91bn in 2026 to US$41.58bn by 2036, at a 15.4% CAGR
The mRNA Contract Manufacturing market is projected to grow at a CAGR of 11.3% by 2036